| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.9 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
AZD-2281 |
FIMM |
pan-cancer |
AAC |
-0.028 |
0.9 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.0088 |
0.9 |
| mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.0079 |
0.9 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |